דביגטרן אס.קיי 110 מג

Pajjiż: Iżrael

Lingwa: Ebrajk

Sors: Ministry of Health

Ingredjent attiv:

DABIGATRAN ETEXILATE

Disponibbli minn:

K.S.KIM INTERNATIONAL LTD

Kodiċi ATC:

B01AE07

Għamla farmaċewtika:

קפסולות

Kompożizzjoni:

DABIGATRAN ETEXILATE 110 MG

Rotta amministrattiva:

פומי

Tip ta 'preskrizzjoni:

מרשם נדרש

Manifatturat minn:

TOWA PHARMACEUTICAL EUROPE, S.L., SPAIN

Żona terapewtika:

DABIGATRAN ETEXILATE

Data ta 'l-awtorizzazzjoni:

2022-12-20

Fuljett ta 'informazzjoni

Page 1 of 9
ʲ
ʯʥʬ
ʯʫʸʶʬ
ʩʴʬ
ʺʥʰʷʺ
ʭʩʧʷʥʸʤ
)
ʭʩʸʩʹʫʺ
(
ʮʹʺʤ
"
ʥ
–
1986
ʤʴʥʸʺʤ
ʺʷʥʥʹʮ
ʬʲ
ʩʴ
ʭʹʸʮ
ʠʴʥʸ
ʣʡʬʡ
.ʩʩʷ .ʱʠ ʯʸʨʢʩʡʣ
110
ʢ"ʮ
ʺʥʱʥʮʫ
ʸʮʥʧʤ
ʬʩʲʴʤ
:
ʫ
ʬ
ʤʱʥʮʫ
ʬʹ
.ʩʩʷ .ʱʠ ʯʸʨʢʩʡʣ
110
ʢ"ʮ
ʤʬʩʫʮ
:
ʯʠʸʨʢʩʡʣ
ʨʬʩʱʷʨʠ
)
ʨʬʩʱʮʫ
(
110
ʢ"ʮ
110 mg
mesilate)
(as
etexilate
Dabigatran
ʳʩʲʱ ʤʠʸ ʭʩʩʰʢʸʬʠʯ ʭʩʬʩʲʴ ʩʺʬʡ
ʭʩʡʩʫʸʮ ʬʲ ʲʣʩʮʬ
2
ʳʩʲʱʥ "ʤʴʥʸʺʤ ʬʹ ʭʩʡʩʫʸʮʤʮ ʷʬʧ ʬʲ ʡʥʹʧ
ʲʣʩʮ"
6
"ʳʱʥʰ ʲʣʩʮ "
ʠʸʷ
ʯʥʩʲʡ
ʺʠ
ʯʥʬʲʤ
ʣʲ
ʥʴʥʱ
ʭʸʨʡ
ʹʮʺʹʺ
ʤʴʥʸʺʡ
.
ʯʥʬʲ
ʤʦ
ʬʩʫʮ
ʲʣʩʮ
ʩʺʩʶʮʺ
ʬʲ
ʤʴʥʸʺʤ
.
ʭʠ
ʹʩ
ʪʬ
ʺʥʬʠʹ
ʺʥʴʱʥʰ
,
ʤʰʴ
ʬʠ
ʠʴʥʸʤ
ʥʠ
ʬʠ
ʧʷʥʸʤ
.
ʤʴʥʸʺ
ʥʦ
ʤʮʹʸʰ
ʬʥʴʩʨʬ
ʪʺʬʧʮʡ
.
ʬʠ
ʸʩʡʲʺ
ʤʺʥʠ
ʭʩʸʧʠʬ
.
ʠʩʤ
ʤʬʥʬʲ
ʷʩʦʤʬ
ʭʤʬ
ʥʬʩʴʠ
ʭʠ
ʤʠʸʰ
ʪʬ
ʩʫ
ʭʺʬʧʮ
ʤʮʥʣ
.
.1
ʤʮʬ
ʺʣʲʥʩʮ
ʤʴʥʸʺʤ
?
.ʩʩʷ .ʱʠ ʯʸʨʢʩʡʣ
110
ʢ"ʮ
ʤʬʩʫʮ
ʺʠ
ʸʮʥʧʤ
ʬʩʲʴʤ
ʯʠʸʨʢʩʡʣ
ʨʬʩʱʷʨʠ
,
ʪʩʩʹʤ
ʺʶʥʡʷʬ
ʺʥʴʥʸʺ
ʺʠʸʷʰʤ
"
ʩʣʢʥʰ
ʤʹʩʸʷ
."
.ʩʩʷ .ʱʠ ʯʸʨʢʩʡʣ
110
ʢ"ʮ
ʺʣʲʥʩʮ
ʭʩʸʢʥʡʮʬ
:
.1
ʺʲʩʰʮʬ
ʺʥʸʶʥʥʩʤ
ʩʹʩʸʷ
ʭʣ
ʭʩʣʩʸʥʥʡ
ʸʧʠʬ
ʭʩʧʥʺʩʰ
ʭʩʩʣʴʥʺʸʥʠ
ʭʩʩʡʩʨʷʬʠ
ʬʹ
ʤʴʬʧʤ
ʤʠʬʮ
ʬʹ
ʷʸʴʮ
ʪʸʩʤ ʷʸʴʮ ʬʹ ʤʠʬʮ ʤʴʬʧʤ ʥʠ ʪʸʡʤ
.
.2
ʺʲʩʰʮʬ
ʵʡʹ
ʳʩʧʱʺʥ
ʩʮʨʱʩʱ
ʭʩʬʥʧʡ
ʭʩʸʢʥʡʮ
ʭʩʬʡʥʱʤ
ʺʥʮʩʲʴʮ
ʡʬ
ʠʬ
ʺʥʸʩʣʱ
)
ʸʥʴʸʴ
ʭʩʸʥʣʦʥʸʴ
(
ʯʰʩʠʹ
ʺʩʮʺʱʮ ʤʬʧʮ ʲʷʸ ʬʲ
.
.3
ʬʥʴʩʨʬ
ʩʹʩʸʷʡ
ʭʣ
ʩʣʩʸʥʥʡ
ʭʩʩʬʢʸʤ
)
ʺʷʷʴʡ
ʭʩʣʩʸʥ
ʤʷʥʮʲ
((DVT)
ʩʬʫʡʥ
ʭʣʤ
ʬʹ
ʺʥʠʩʸʤ
)
ʳʩʧʱʺ
ʩʺʠʩʸ
((PE)
ʺʲʩʰʮʥ
ʺʥʰʹʩʤ
ʩʹʩʸʷ
ʭʣ
ʩʬʫʡ
ʭʣ
ʥʬʠ
.
ʤʶʥʡʷ
ʺʩʨʩʥʴʸʺ
:
ʩʣ�